Medical Devices Research Reports Surgical Navigation System Market | Page 3

Coherent Market Insights

3

Browse 41 Market Data Tables and 37 Figures spread through 185 Pages and in-depth TOC on "Surgical navigation system Market, by Application (Neurological Surgeries, ENT Surgeries, Orthopedic Surgeries, Cardiac Surgeries and Dental Surgeries), by Technology (Optical Navigation System, Electromagnetic Navigation System and Hybrid Navigation System), by End User (Hospital and Nursing Home, Ambulatory Surgical Centers and Other End Users) - Global Forecast to 2026"

To know the latest trends and insights related to surgical navigation system market, click the link below:

https://www.coherentmarketinsights.com/market-insight/surgical-navigation-system-market-1690

Manufacturer’s strategies like merger and collaboration will further strengthen the growth of the surgical navigation system market. For instance, in 2017, Mazor Robotics Ltd., manufacturer of surgical guidance system, entered the next phase of strategic partnership with Medtronic. The partnership aims at co-development of spinal market product with the expertise in surgical planning and precision-guided surgical system with Medtronic’s navigation capabilities and implant system. Moreover, according to these partnership Medtronic invests US$ 40 million in Mazor. New product launches with more precision will further augment the growth of the market. For example, Zimmer Holding Inc., a musculoskeletal health technology company, received US FDA approval for iAssist Knee, a personalized guidance system for knee replacement procedures. iAssist Knee supports more streamline and personalized knee replacement procedures. Manufacturers are also target at expanding the geographical reach of the product. In October 2017, Intellijoint Surgical, a medical technology company, received CE approval for its intellijoint HIP, a 3D Mini-Optical Navigation System, in Europe. The system is aids surgeons to precisely measure cup position, leg length and offset for total hip arthroplasty. Further, company is expecting approval from Australian Therapeutic Goods Administration (TGA) by November 2017.